Published Date: 17 Feb 2023
Many fears arise in childhood. And the science is very clear. Observational fear learning is especially common in children who model their fear without parental support.
Read Full NewsThe 1-hour troponin pathway was safely implemented in a real-world study but did not impact workflow in busy emergency departments.
Edoxaban reduced ischemic stroke after intracranial hemorrhage in patients with AF, but excess hemorrhagic stroke and major bleeding offset the benefit.
A multicenter phase 3 trial has associated a cardiac myosin inhibitor with meaningful clinical benefit in nonobstructive HCM, for which there has been no effective therapies.
Tailored antibiotic therapy for infective endocarditis was associated with a significant reduction in treatment duration, according to an open-label multicenter trial.
1.
A study outlines the need for policies that enhance cancer patients' autonomy and information.
2.
Novel biomarker has potential for predicting and treating skin cancer metastasis
3.
PSMA PET: Prostate Cancer Staging Revolution Awaits RCT Data
4.
UK study evaluates effectiveness of cancer diagnosis pathway for patients with non-specific symptoms
5.
For patients with breast cancer receiving chemotherapy, exercise may help lessen the long-term side effects.
1.
From Bruises to Blood Clots: Everything You Need to Know about Hematoma
2.
Understanding Thrombin Time: What It Is and How It Can Help Diagnose Blood Clotting Disorders
3.
Adjuvant Atezolizumab in TNBC: What Recent Trials Reveal About Its Role
4.
The Latest Causes and Symptoms of Bowen's Disease: All You Need to Know
5.
Revolutionizing Cancer Treatment: The Promise of Bevacizumab Injections
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part V
2.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
3.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Summarization of the New Perspective
5.
From Relapse to Remission : Chasing the Invisible and Redefining Long-Term Survival in Adult R/R B-Cell ALL
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation